Sanofi and GSK have pledged 200 million Covid-19 vaccine doses to a global alliance SOPA Images/LightRocket via Getty ImagesKey FactsWhile the agreement is not legally binding — it is just a signed statement of intent — Gavi, who co-lead the alliance, says it is an “important step” in ensuring equitable access to Covid-19 vaccines around the world. If realized, the promised doses would go a long way to achieving the COVAX initiative’s goal of procuring and delivering 2 billion doses of Covid-19 vaccine by the end of 2021. The GSK-Sanofi vaccine has yet to be approved, no vaccine has, and is still undergoing early-stage clinical trials. “Vaccine nationalism will prolong the pandemic, not shorten it,” he said, repeating the phrase for emphasis. Further ReadingSanofi, GSK to provide COVID-19 vaccine to global alliance (AP News)U.S. Won’t Join Global Coronavirus Vaccine Effort Because It’s Led By The WHO (Forbes)WHO Warns Of ‘Dangerous Moment’ Amid Spike In Covid-19 Cases (Forbes)Full coverage and live updates on the Coronavirus

Source: Forbes October 28, 2020 13:07 UTC